| Market Capitalization (Millions $) |
36 |
| Shares
Outstanding (Millions) |
7 |
| Employees |
115 |
| Revenues (TTM) (Millions $) |
15 |
| Net Income (TTM) (Millions $) |
-63 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
1 |
Business Description
Generation Bio Co is a biotechnology company that is dedicated to developing cutting-edge gene therapy treatments for rare genetic diseases. The company was founded in 2016 by a team of experienced scientists from top institutions like Harvard Medical School, MIT, and the Broad Institute.
The central focus of Generation Bio Co's work is to create gene therapies that utilize adeno-associated viruses (AAV) as vectors to deliver genetic payloads to specific cells in the body. This approach allows for the correction or replacement of defective genes, which is essential for the treatment of countless inherited disorders.
One of the key innovations that sets Generation Bio Co apart is its robust and versatile genetic engineering platform. This platform incorporates various techniques like directed evolution, DNA shuffling, and high-throughput screening to create novel AAV vectors that are highly effective at delivering therapeutic genes to target cells.
The company's founders have a deep commitment to pursuing safe and effective gene therapies. As such, they have developed rigorous safety protocols and are following strict guidelines set by the FDA for clinical trials. Generation Bio Co also emphasizes transparency, ethics, and the involvement of patients and families in the development process.
Currently, Generation Bio Co is working on several promising gene therapy programs across a range of genetic diseases, including hemophilia, phenylketonuria, and spinal muscular atrophy. These therapies have shown impressive results in preclinical studies and are poised to move into clinical trials in the near future.
In summary, Generation Bio Co is a biotechnology company that is focused on developing advanced gene therapies for the treatment of rare genetic diseases. The company is driven by a talented team of scientists who employ innovative technologies to create effective and safe genetic therapies. With a robust pipeline of promising therapies, Generation Bio Co is poised to make a significant impact on the field of gene therapy and the lives of millions of people around the world.
Company Address: 301 Binney Street Cambridge 2142 MA
Company Phone Number: 655-7500 Stock Exchange / Ticker: NASDAQ GBIO
|
0.05% 
100 %